Boston Common Asset Management LLC Sells 6,282 Shares of Relx Plc $RELX

Boston Common Asset Management LLC decreased its stake in shares of Relx Plc (NYSE:RELX) by 5.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 99,966 shares of the technology company’s stock after selling 6,282 shares during the period. Boston Common Asset Management LLC’s holdings in Relx were worth $5,432,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in RELX. Rhumbline Advisers increased its position in shares of Relx by 1.2% during the first quarter. Rhumbline Advisers now owns 34,906 shares of the technology company’s stock worth $1,760,000 after acquiring an additional 411 shares in the last quarter. Merit Financial Group LLC increased its position in shares of Relx by 77.7% during the first quarter. Merit Financial Group LLC now owns 11,757 shares of the technology company’s stock worth $593,000 after acquiring an additional 5,139 shares in the last quarter. Blue Zone Wealth Advisors LLC increased its position in shares of Relx by 11.0% during the first quarter. Blue Zone Wealth Advisors LLC now owns 123,841 shares of the technology company’s stock worth $6,243,000 after acquiring an additional 12,303 shares in the last quarter. Sivia Capital Partners LLC acquired a new position in Relx during the first quarter worth $224,000. Finally, Park Avenue Securities LLC boosted its holdings in Relx by 6.3% during the first quarter. Park Avenue Securities LLC now owns 65,050 shares of the technology company’s stock worth $3,279,000 after purchasing an additional 3,877 shares during the last quarter. Institutional investors own 15.02% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on RELX. Wall Street Zen cut shares of Relx from a “buy” rating to a “hold” rating in a report on Friday, September 5th. Kepler Capital Markets upgraded shares of Relx from a “hold” rating to a “strong-buy” rating in a report on Thursday, September 18th. Weiss Ratings restated a “buy (b)” rating on shares of Relx in a report on Saturday, September 27th. Finally, Morgan Stanley restated an “overweight” rating on shares of Relx in a report on Thursday, September 11th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy”.

Relx Stock Performance

Shares of RELX stock opened at $46.43 on Friday. The stock has a market cap of $85.09 billion, a P/E ratio of 24.96, a P/E/G ratio of 3.03 and a beta of 0.87. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The company has a fifty day moving average price of $47.85 and a two-hundred day moving average price of $50.96. Relx Plc has a one year low of $44.19 and a one year high of $56.33.

Relx Cuts Dividend

The company also recently declared a semi-annual dividend, which was paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th were paid a $0.2634 dividend. The ex-dividend date was Friday, August 8th. This represents a yield of 170.0%. Relx’s dividend payout ratio (DPR) is currently 28.49%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.